32
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

THE ROLE OF ANTISENSE OLIGONUCLEOTIDES IN THE WAVE OF GENOMIC INFORMATION

Pages 397-399 | Published online: 07 Feb 2007

REFERENCES

  • http://ncbi.nlm.nigh.gov/Genomes/index.html
  • Pennisi , E. 2000 . HUMAN GENOME: DOE team sequences three chromosomes . Science , 288 ( 5465 ) : 417 – 419 .
  • Dunham , I. , Shimizu , N. , Roe , B. A. , Chissoe , S. , Hunt , A. R. , Collins , J. E. , Bruskiewich , R. , Beare , D. M. , Clamp , M. , Smink , L. J. , Ainscough , R. , Almeida , J. P. , Babbage , A. , Bagguley , C. , Bailey , J. , Barlow , K. , Bates , K. N. , Beasley , O. , Bird , C. P. , Blakey , S. , Bridgeman , A. M. , Buck , D. , Burgess , J. , Burrill , W. D. , O'Brien , K. P. and et al. 1999 . The DNA sequence of human chromosome 22 . Nature , 402 ( 6761 ) : 489 – 95 .
  • Koller , E. , Gaarde , W. A. and Monia , B. P. 2000 . Elucidating cell signaling mechanisms using antisense technology . Trends pharmacol. Sci. , 21 ( 4 ) : 142 – 8 .
  • Zhang , H. , Cook , J. , Nickel , J. , Yu , R. , Stecker , K. , Myers , K. and Dean , N. M. 2000 . Reduction of Liver Fas expression by an antisense olignucleotide protects mice from fulminant hepatitis . Nat. Biotech. , 18 ( 8 ) : 862 – 67 .
  • Lebedeva , I. , Benimetskaya , L. , Stein , C. A. and Vilenchik , M. 2000 . Cellular delivery of antisense oligonucleotides . Eur. J. Pharm. Biopharm. , 50 ( 1 ) : 101 – 19 .
  • Levin , A. A. 1999 . A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides . Biochem. Biophys. Acta , 1489 ( 1 ) : 69 – 84 .
  • Bennett , C. F. 1999 . Antisense oligonucleotide therapeutics . Exp. Opin. Invest. Drugs , 8 ( 3 ) : 237 – 53 .
  • Crooke , S. T. 1998 . Antisense therapeutics . Biotech. Genet. Eng. Rev. , 15 : 121 – 57 .
  • Bennett , C. F. and Cowsert , L. M. 1999 . Antisense oligonucleotides as a tool for gene functionalization and target validation . Biochem. Biophys. Acta , 148 ( 1 ) : 19 – 30 .
  • Monia , B. P. 1997 . First and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo Studies . Anti-Cancer Drug Design , 12 ( 5 ) : 327 – 39 .
  • McKay , R. A. , Miraglia , L. J. , Cummins , L. L. , Owens , S. R. , Sasmor , H. and Dean , N. M. 1999 . Characterization of a potent and specific class of antisense oligonucleotide inibitor of human protein kinase C-α expression . J. Biol. Chem. , 274 ( 3 ) : 1715 – 22 .
  • Herbert , A. and Rich , A. 1999 . RNA processing and the evolution of eukaryotes . Nat. Genet. , 21 : 265 – 269 .
  • Karras , J. G. , Mckay , R. A. , Dean , N. M. and Monia , B. P. 2000 . Deletion of individual exons and induction of soluble murine interleukin-5 receptor-a chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing . Mol. Pharmacol. , 58 ( 2 ) : 380 – 87 .
  • Taylor , J. K. , Zhang , Q. Q. , Wyatt , J. R. and Dean , N. M. 1999 . Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides . Nat. Biotech. , 17 : 1097 – 1100 .
  • Baker , B. F. and Monia , B. P. 1999 . Novel mechanisms for antisense-mediated regulation of gene expression . Biochim. Biophys. Acta , 1489 ( 1 ) : 3 – 18 .
  • Mercatante , D. and Kole , R. 2000 . Modification of alternative splicing pathways as a potential approach to chemotherapy . Pharmacol. Ther. , 85 ( 3 ) : 237 – 43 .
  • Taylor , J. K. and Dean , N. M. 1999 . Regulation of pre-mRNA splicing by antisense oligonucleotides . Curr. Opin. Drug Discov. , 2 ( 2 ) : 147 – 151 .
  • Dias , N. , Dheur , S. , Nielsen , P. E. , Gryaznov , S. , Van Aerschot , A. , Herdewijn , P. , Helene , C. and Saison-Behmoaras , T. E. 1999 . Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation . J. Mol. Biol. , 294 ( 2 ) : 403 – 16 .
  • Baker , B. F. , Lot , S. S. , Condon , T. P. , Cheng-Flournoy , S. , Lesnik , E. A. , Sasmor , H. M. and Bennett , C. F. 1997 . 2′-O-(2-Methoxyethyl) modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells . J. Biol. Chem. , 272 ( 18 ) : 11994 – 12000 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.